Jump Financial, LLC Oncocyte Corp Transaction History

Jump Financial, LLC

  • $4.56 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 09, 2022
BUY
$0.86 - $1.53 $25,060 - $44,584
29,140 New
29,140 $26,000
Q1 2022

May 12, 2022
SELL
$1.15 - $2.25 $84,755 - $165,825
-73,700 Closed
0 $0
Q4 2021

Feb 10, 2022
BUY
$2.04 - $3.59 $116,280 - $204,630
57,000 Added 341.32%
73,700 $160,000
Q3 2021

Nov 12, 2021
SELL
$3.53 - $5.89 $561 - $936
-159 Reduced 0.94%
16,700 $59,000
Q2 2021

Aug 13, 2021
BUY
$3.77 - $6.0 $63,558 - $101,154
16,859 New
16,859 $97,000

Others Institutions Holding OCX

# of Institutions
3
Shares Held
411K
Call Options Held
0
Put Options Held
0
View Full List

About Oncocyte Corp

OCX Quotes by TradingView
  • Ticker OCX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 118,609,000
  • Market Cap $260M
  • Description
  • OncoCyte Corporation, a molecular diagnostics company, researches, develops, and commercializes proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company offers DetermaRx, a molecular test for early-stage adenocarcinoma of the lung; and DetermaIO, a proprietary gene expression assay....
More about OCX
Track This Portfolio

Track Jump Financial, LLC Portfolio

Follow Jump Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jump Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jump Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email